×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MTEM – molecular templates, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MTEM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
09:50 pm
mtem
Form SC 13G/A Molecular Templates, Filed by: BB BIOTECH AG
High
Report
Form SC 13G/A Molecular Templates, Filed by: BB BIOTECH AG
11/18
09:12 pm
mtem
Form 4 Molecular Templates, For: Nov 14 Filed by: BB BIOTECH AG
High
Report
Form 4 Molecular Templates, For: Nov 14 Filed by: BB BIOTECH AG
11/15
06:13 am
mtem
Form NT 10-Q Molecular Templates, For: Sep 30
High
Report
Form NT 10-Q Molecular Templates, For: Sep 30
11/14
04:38 pm
mtem
Form SC 13G/A Molecular Templates, Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SC 13G/A Molecular Templates, Filed by: BIOTECHNOLOGY VALUE FUND L P
11/12
09:35 am
mtem
Form SC 13G/A Molecular Templates, Filed by: Adage Capital Management, L.P.
Medium
Report
Form SC 13G/A Molecular Templates, Filed by: Adage Capital Management, L.P.
10/28
05:21 pm
mtem
Form DEF 14A Molecular Templates, For: Nov 26
High
Report
Form DEF 14A Molecular Templates, For: Nov 26
10/17
05:06 pm
mtem
Form PRE 14A Molecular Templates, For: Oct 17
Medium
Report
Form PRE 14A Molecular Templates, For: Oct 17
10/11
04:39 pm
mtem
Form 8-K Molecular Templates, For: Oct 11
High
Report
Form 8-K Molecular Templates, For: Oct 11
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/20
Molecular Templates, Inc. Announces Proposed Public Equity Offering
46.7%
3/12 Q4/2019 12/31/2019 EPS -0.410 ZacksConsensus N/A ActVsEst N/A - N/A 19.9%
11/27 Form 4 Molecular Templates, For: Nov 25 Filed by: Hirsch David 17.1%
12/19 Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors 16.4%
12/3 Form D/A Molecular Templates, 12.4%
2/28 Molecular Templates to Present at Three March Investor Conferences 10.1%
11/23 Molecular Templates Inc (NASDAQ: MTEM) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 9.1%
11/7 Molecular Templates Hosting Analyst & Investor Meeting 7.9%
2/5 Molecular Templates Inc (NASDAQ: MTEM) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 7.8%
2/18 Form 4 Molecular Templates, For: Feb 14 Filed by: Kim Jason S. 7.3%
3/12 Q4/2019 12/31/2019 EPS -0.410 ZacksConsensus N/A ActVsEst N/A - N/A 19.9%
11/27 Form 4 Molecular Templates, For: Nov 25 Filed by: Hirsch David 17.1%
12/19 Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors 16.4%
12/3 Form D/A Molecular Templates, 12.4%
2/28 Molecular Templates to Present at Three March Investor Conferences 10.1%
11/23 Molecular Templates Inc (NASDAQ: MTEM) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 9.1%
11/7 Molecular Templates Hosting Analyst & Investor Meeting 7.9%
2/5 Molecular Templates Inc (NASDAQ: MTEM) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 7.8%
2/18 Form 4 Molecular Templates, For: Feb 14 Filed by: Kim Jason S. 7.3%
TOP News Decliners
11/12
Q3/2019 9/30/2019 EPS -1.030 ZacksConsensus -0.230 ActVsEst (0.800) - Miss
-17.8%
11/14 Translational Research in Oncology (TRIO) Initiates Phase I Study for MT-5111 -8.9%
10/28 What Kind Of Shareholders Own Molecular Templates, Inc. (NASDAQ:MTEM)? [Yahoo! Finance News] -4.4%
5/30 Form 4 Molecular Templates, For: May 29 Filed by: Hirsch David -4.3%
1/3 Form 4 Molecular Templates, For: Jan 03 Filed by: Kim Jason S. -4.0%
2/27 Molecular Templates Inc (NASDAQ: MTEM) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock. -3.8%
9/23 Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences -3.8%
3/6 Molecular Templates Inc (NASDAQ: MTEM) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -3.4%
11/27 Form D Molecular Templates, -3.4%
6/5 Molecular Templates Inc (NASDAQ: MTEM) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.0%
11/14 Translational Research in Oncology (TRIO) Initiates Phase I Study for MT-5111 -8.9%
10/28 What Kind Of Shareholders Own Molecular Templates, Inc. (NASDAQ:MTEM)? [Yahoo! Finance News] -4.4%
5/30 Form 4 Molecular Templates, For: May 29 Filed by: Hirsch David -4.3%
1/3 Form 4 Molecular Templates, For: Jan 03 Filed by: Kim Jason S. -4.0%
2/27 Molecular Templates Inc (NASDAQ: MTEM) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock. -3.8%
9/23 Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences -3.8%
3/6 Molecular Templates Inc (NASDAQ: MTEM) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -3.4%
11/27 Form D Molecular Templates, -3.4%
6/5 Molecular Templates Inc (NASDAQ: MTEM) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: